Financial Year |
March 31 2023 |
Monetary Funds |
5,212,566,453.34 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
2,358,944,656.19 |
Accounts Receivable |
5,528,948,724.10 |
Advances to Suppliers |
174,065,944.20 |
Other Receivables |
28,256,628.35 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
3,479,114,275.49 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
14,788,429.27 |
Total Current Assets |
17,023,675,926.93 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
7,476,100.00 |
Long-term Equity Investment |
861,041,938.30 |
Investment Properties |
10,789,975.69 |
Fixed Assetes |
2,417,230,700.08 |
Under-construction Projects |
745,699,862.43 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
344,764,671.58 |
R&D expenses |
-- |
Goodwill |
40,946,134.90 |
Long-Term Deferred and Prepaid Expenses |
4,637,118.24 |
Deferred Income Tax Assets |
215,564,525.84 |
Other Non-Current Assets |
366,557,721.51 |
Sub-Total of Non-Current Assets |
5,140,213,197.36 |
Total Assets |
22,163,889,124.29 |
Short-Term Loans |
304,050,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
2,798,234,184.98 |
Accounts Payable |
3,527,361,398.57 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
113,770,119.70 |
Taxes Payable |
112,498,400.25 |
Interest Payable |
-- |
Dividend Payable |
902,503.45 |
Other payables |
148,485,986.47 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
1,998,448,624.57 |
Other Current Liabilities |
468,805,747.98 |
Sub-Total of Current Liabilities |
10,184,776,188.02 |
Long-term Loans |
435,730,000.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
307,558,693.17 |
Special Payable |
-- |
Estimatied Liabilities |
1,530,638.00 |
Deferred Income Tax Liabilities |
33,006,478.96 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
879,163,841.32 |
Total Liabilities |
11,063,940,029.34 |
Paid-In Capital(Or Share Stock) |
1,472,049,090.00 |
Capital Surplus |
4,461,374,803.69 |
Surplus Reserve |
209,871,748.86 |
LESS:Treasury Stock |
27,123,408.26 |
Undistributed Profits |
4,529,452,569.93 |
Minority Stockholder's Interest |
419,685,731.23 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,680,263,363.72 |
Owner's Equity(Stockholder's Equity) |
11,099,949,094.95 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
22,163,889,124.29 |